Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml |
Is a |
difterivaccine |
false |
Inferred relationship |
Some |
|
|
difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml |
Is a |
tetanusvaccine |
false |
Inferred relationship |
Some |
|
|
difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml |
Is a |
Haemophilus influenzae type b-vaccine |
false |
Inferred relationship |
Some |
|
|
difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
tetanustoxoid |
false |
Inferred relationship |
Some |
|
|
difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
vaccine mod influenzavirus |
false |
Inferred relationship |
Some |
|
|
difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
difterivaccine |
false |
Inferred relationship |
Some |
|
|
difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
vaccine mod Haemophilus influenzae type B |
false |
Inferred relationship |
Some |
|
|
difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml |
Is a |
difteri- + tetanus- + Haemophilus influenzae type b-vaccine |
false |
Inferred relationship |
Some |
|
|
difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml |
Has manufactured dose form |
injektionsvæske |
false |
Inferred relationship |
Some |
|
|
difteri- og tetanustoxoid + Haemophilus influenzae type B-vaccine, konjugeret, 0,6 ml/0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Diphtheria vaccine |
false |
Inferred relationship |
Some |
|
|